Efficacy Study: Darbepoetin Alfa for the Treatment of Anemia in Patients With Chronic Kidney Disease
Status:
Completed
Trial end date:
2006-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate whether the efficacy of darbepoetin alfa SF is
equivalent to that of darbepoetin alfa RB for the treatment of anemia in patients with
chronic kidney disease (CKD) receiving hemodialysis.